Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Theranostic Guided Riboflavin/UV-A Corneal Cross-linking for Treatment of Keratoconus

NCT05457647 is registered in ClinicalTrials.gov with Regensight as lead sponsor.

NCT NCT05457647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05457647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Theranostic Guided Riboflavin/UV-A Corneal Cross-linking for Treatment of Keratoconus
Lead sponsor
Regensight
Phase
Not applicable
Overall status
Completed
Start date
April 27, 2022
Completion date
January 26, 2024
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus